Vinorelbine Export Market Intelligence: India's 78 Suppliers Shipping to 60 Countries — TransData Nexus 2026

Q: Who are the top vinorelbine exporters from India?

The top vinorelbine exporters from India are: 1. INTAS PHARMACEUTICALS LIMITED — $1.3M (37.1% market share); 2. EUGIA PHARMA SPECIALITIES LIMITED — $776.6K (22.9% market share); 3. FRESENIUS KABI ONCOLOGY LIMITED — $512.3K (15.1% market share); 4. UNITED BIOTECH PRIVATE LIMITED — $110.1K (3.2% market share); 5. NV REMEDIES PRIVATE LIMITED — $101.6K (3.0% market share). Together they account for 81.4% of India's total vinorelbine export value.

Q: What is the total export value of vinorelbine from India?

The total export value of vinorelbine from India is $3.4M USD, recorded across 439 shipment transactions from 78 active exporters to 60 destination countries. The average shipment value is $7.7K.

Q: Which countries import vinorelbine from India?

India exports vinorelbine to 60 countries worldwide. The top importing countries are: MALTA (22.9% share, $776.6K), NETHERLANDS (19.8% share, $670.2K), POLAND (14.7% share, $496.8K), PAKISTAN (10.1% share, $341.2K), VENEZUELA (5.8% share, $195.0K). These five markets account for 73.2% of total export value.

Q: What is the HS code for vinorelbine exports from India?

The primary HS code for vinorelbine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of vinorelbine exports from India?

The average unit price for vinorelbine exports from India is $21.45 USD per unit, with prices ranging from $0.50 to $310.91 depending on formulation, packaging, and order volume. The total market is valued at $3.4M across 439 shipments.

Q: Which ports handle vinorelbine exports from India?

The primary ports for vinorelbine exports from India are SAHAR AIR (13.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (12.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.6% of shipments), MUNDRA SEA (INMUN1) (11.6% of shipments), AHEMDABAD AIR ACC (INAMD4) (10.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of vinorelbine?

India is one of the world's leading exporters of vinorelbine due to its large base of 78 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports vinorelbine to 60 countries, demonstrating 31% global market coverage.

Q: What certifications do Indian vinorelbine exporters need?

Indian vinorelbine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import vinorelbine from India?

There are 138 registered buyers importing vinorelbine from India, spread across 60 countries. The repeat buyer rate is 48.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top vinorelbine supplier from India?

INTAS PHARMACEUTICALS LIMITED is the leading vinorelbine exporter from India with a market share of 37.1% and total export value of $1.3M across 164 shipments. The top 5 suppliers together control 81.4% of total export value.

Suresh Sormare

Vinorelbine

India Pharmaceutical Trade Intelligence

$3.4M78 Suppliers60 CountriesHS 30049049

ExportsIndia → MALTA22.9%India → NETHERLANDS19.8%

ImportsFRANCE → India$488.9K UNITED STATES → India$5.2K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: BROCACEF NL

Vinorelbine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Vinorelbine to the World

Between 2022 and 2026, India exported $3.4M worth of vinorelbine across 439 verified shipments to 60 countries — covering 31% of world markets in the Advanced Oncology segment. The largest destination is MALTA (22.9%). INTAS PHARMACEUTICALS LIMITED leads with a 37.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Vinorelbine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Vinorelbine export data snapshot — $3.4M · 78 exporters · 60 countriesTransData Nexus · Indian Customs Data

Top Vinorelbine Exporters from India

78 active exporters · Ranked by export value

View all 78 →

Top Vinorelbine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	INTAS PHARMACEUTICALS LIMITED	$1.3M	164	6	37.1%
2	EUGIA PHARMA SPECIALITIES LIMITED

Top Countries Importing Vinorelbine from India

60 destination markets · Ranked by import value

All 60 countries →

Top Countries Importing Vinorelbine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MALTA	$776.6K	22.9%
2	NETHERLANDS	$670.2K	19.8%
3	POLAND	$496.8K	14.7%
4	PAKISTAN	$341.2K	10.1%
5	VENEZUELA	$195.0K	5.8%
6	CONGO	$101.6K	3.0%
7	MALAYSIA	$98.5K	2.9%
8	SENEGAL	$98.1K	2.9%
9	MOROCCO	$89.7K	2.6%
10	UNITED KINGDOM	$66.2K	2.0%

MALTA is India's largest vinorelbine export destination, absorbing 22.9% of total exports worth $776.6K. The top 5 importing countries — MALTA, NETHERLANDS, POLAND, PAKISTAN, VENEZUELA — together account for 73.2% of India's total vinorelbine export value. The remaining 55 destination countries collectively receive the other 26.8%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Vinorelbine to India?

2 origin countries · Total import value: $494.1K

India imports vinorelbine from 2 countries with a combined import value of $494.1K. The largest supplier is FRANCE ($488.9K, 8 shipments), followed by UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Vinorelbine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	FRANCE	$488.9K	8	98.9%
2	UNITED STATES	$5.2K	7	1.1%

FRANCE is the largest supplier of vinorelbine to India, accounting for 98.9% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Vinorelbine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Vinorelbine received FDA approval in December 1994 for the treatment of non-small cell lung cancer. The original brand, Navelbine, manufactured by Pierre Fabre, was approved in an injectable formulation. However, all formulations of Navelbine have since been discontinued. As of February 12, 2026, there are no active generic versions of Navelbine available in the U.S. market.

The absence of active Abbreviated New Drug Applications (ANDAs) for vinorelbine in the U.S. suggests limited competition, potentially impacting market dynamics. Given that 78 Indian exporters are actively involved in vinorelbine exports, there exists an opportunity for these manufacturers to explore the U.S. market, provided they navigate the FDA's regulatory pathways effectively.

2EU & UK Regulatory Framework

In the European Union, vinorelbine is approved for the treatment of non-small cell lung cancer and metastatic breast cancer. The European Medicines Agency (EMA) has conducted periodic safety update report single assessments (PSUSAs) for vinorelbine, with the most recent procedure (PSUSA/00003124/202204) resulting in a variation to the marketing authorization as of January 24, 2023. (ema.europa.eu)

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring compliance with Good Manufacturing Practice (GMP) guidelines for marketing authorization holders. Indian exporters targeting these markets must ensure adherence to EU GMP standards to facilitate market entry.

3WHO Essential Medicines & Global Standards

Vinorelbine is listed on the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global health. The 24th edition of the list, published in September 2025, includes vinorelbine, reflecting its essential status. (who.int)

Inclusion in the WHO Model List facilitates its adoption in national essential medicines lists, potentially increasing demand in various countries. Manufacturers must ensure compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to meet quality requirements across different markets.

4India Regulatory Classification

In India, vinorelbine is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription drug requiring medical supervision. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, vinorelbine is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics.

For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. Exporters must ensure compliance with these requirements to facilitate smooth international trade.

5Patent & Exclusivity Status

The primary patents for vinorelbine have expired, leading to the availability of generic versions in various markets. This expiration has intensified competition among manufacturers, including Indian exporters, who now have the opportunity to capture market share by offering cost-effective alternatives.

6Recent Industry Developments

In May 2025, the WHO's 25th Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming vinorelbine's inclusion and highlighting its continued relevance in cancer treatment. (who.int)

In January 2023, the EMA concluded a PSUSA for vinorelbine, resulting in variations to the product information to enhance safety and efficacy profiles. (ema.europa.eu)

In July 2023, the WHO published the 9th edition of the Model List of Essential Medicines for Children, emphasizing the importance of essential medicines in pediatric care. (who.int)

In September 2025, the WHO released the 24th edition of the Model List of Essential Medicines, which includes vinorelbine, underscoring its essential status in global health. (who.int)

In December 2018, the EMA granted orphan designation to vinorelbine tartrate for the treatment of soft tissue sarcoma, recognizing its potential in addressing rare cancers. (ema.europa.eu)

These developments reflect the dynamic regulatory environment surrounding vinorelbine, necessitating continuous monitoring by stakeholders to ensure compliance and capitalize on emerging opportunities.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Vinorelbine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Vinorelbine, a chemotherapy agent, is primarily produced in India and China. According to the U.S. Pharmacopeia, 58% of Key Starting Materials (KSMs) for U.S.-approved Active Pharmaceutical Ingredients (APIs) are sourced from a single country, with 41% from China and 16% from India. This heavy reliance on these nations for KSMs introduces significant supply chain vulnerabilities.

Recent geopolitical tensions have exacerbated these risks. In March 2026, the closure of the Strait of Hormuz disrupted the supply of raw materials to Asia's petrochemical industry, leading to production cutbacks and force majeure declarations. Such disruptions can have cascading effects on the availability of APIs like Vinorelbine, highlighting the fragility of current sourcing strategies.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Vinorelbine account for 81.4% of total exports, with INTAS PHARMACEUTICALS LIMITED alone contributing 37.1%. This high concentration poses a significant single-source risk. While India's Production Linked Incentive (PLI) scheme aims to bolster domestic API production and reduce import dependence, its full impact on diversifying Vinorelbine suppliers remains to be seen.

Geopolitical & Shipping Disruptions

Access Complete Vinorelbine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 439 transactions across 60 markets.

Request Demo View Pricing

Frequently Asked Questions — Vinorelbine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top vinorelbine exporters from India?

The leading vinorelbine exporters from India are INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, and 8 others. INTAS PHARMACEUTICALS LIMITED leads with 37.1% market share ($1.3M). The top 5 suppliers together control 81.4% of total export value.

What is the total export value of vinorelbine from India?

The total export value of vinorelbine from India is $3.4M, recorded across 439 shipments from 78 active exporters to 60 countries. The average shipment value is $7.7K.

Which countries import vinorelbine from India?

India exports vinorelbine to 60 countries. The top importing countries are MALTA (22.9%), NETHERLANDS (19.8%), POLAND (14.7%), PAKISTAN (10.1%), VENEZUELA (5.8%), which together account for 73.2% of total export value.

What is the HS code for vinorelbine exports from India?

The primary HS code for vinorelbine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vinorelbine

Vinorelbine

How India Exports Vinorelbine to the World

Top Vinorelbine Exporters from India

Top Countries Importing Vinorelbine from India

Who Supplies Vinorelbine to India?

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Vinorelbine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Vinorelbine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Geopolitical & Shipping Disruptions

Access Complete Vinorelbine Trade Intelligence

Frequently Asked Questions — Vinorelbine Exports from India

Who are the top vinorelbine exporters from India?

What is the total export value of vinorelbine from India?

Which countries import vinorelbine from India?

What is the HS code for vinorelbine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Risk Mitigation Recommendations

What is the average price of vinorelbine exports from India?

Which ports handle vinorelbine exports from India?

Why is India a leading exporter of vinorelbine?

What certifications do Indian vinorelbine exporters need?

How many buyers import vinorelbine from India?

What is the market share of the top vinorelbine exporter from India?

Analysis Methodology